Skip to search formSkip to main contentSkip to account menu

BI 6

Known as: BI-6 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Pyridinium Compounds

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Fair free-form surfaces that are almost everywhere parametrically C2
2009
2009
Bi-3 C2 polar subdivision
Popular subdivision algorithms like Catmull-Clark and Loop are C2 almost everywhere, but suffer from shape artifacts and reduced… 
2009
2009
Bi-3 C 2 polar subdivision
Popular subdivision algorithms like Catmull-Clark and Loop are C2 almost everywhere, but suffer from shape artifacts and reduced… 
2007
2007
Potency of Five Structurally Different Acetylcholinesterase Reactivators to Reactivate Human Brain Cholinesterases Inhibited by Cyclosarin
Acetylcholinesterase (AChE; EC 3.1.1.7) reactivators are used as a part of the antidotal therapy of organophosphorus pesticide… 
2006
2006
In Vitro Potency of H Oximes (HI-6, HLö-7), the Oxime BI-6, and Currently Used Oximes (Pralidoxime, Obidoxime, Trimedoxime) to Reactivate Nerve Agent-Inhibited Rat Brain Acetylcholinesterase
The efficacy of H oximes (HI-6, HLö-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to… 
2005
2005
Signs of cyclosarin-induced neurotoxicity and its pharmacological treatment with quaternary pyridinium-oximes reactivators.
Highly Cited
2004
Highly Cited
2004
Reactivation of Cyclosarin-inhibited Rat Brain Acetylcholinesterase by Pyridinium–Oximes
Cyclohexyl methylphosphonofluoridate (cyclosarin, cyclosin, GF) is a highly toxic organophosphate, which is resistant to… 
Highly Cited
1999
Highly Cited
1999
A comparison of the efficacy of acetylcholinesterase reactivators against cyclohexyl methylphosphonofluoridate (GF agent) by in vitro and in vivo methods.
The purpose of this study was to compare the therapeutic efficacy of a new acetylcholinesterase reactivator, designated BI-6 (1… 
Highly Cited
1999
Highly Cited
1999
A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with currently available oximes and H oximes against soman by in vitro and in vivo methods.
1998
1998
A comparison of the efficacy of new asymmetric bispyridinium oxime BI-6 with other oximes (obidoxime, HI-6) against soman in rats
1 The influence of three oximes (obidoxime, HI-6 and the new asymmetric bispyridinium oxime BI-6) in combination with atropine on… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)